Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

AirXpanders Installs New CFO/COO

This article was originally published in Clinica

Executive Summary

Scott Murcray has joined tissue expander specialist AirXpanders as chief financial officer/ chief operating officer, as the company is set to grow its operations beyond Australia and into the US. Murcray brings over 20 years of financial experience to AirXpanders, and has held senior finance and management roles at Nanometrics, Zoll Medical, and VNUS Medical Technologies. His appointment was announced together with news that AirXpanders had raised $20m in additional capital through a private placement. The Australia Stock Exchange-listed company will used the proceeds to grow sales of its AeroForm tissue expander in Australia, as well as to support the US launch of the product pending FDA clearance. The firm anticipates the launch to take place in 2017.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst